Platinum rechallenge in the era of immune checkpoint inhibitor in locally advanced/metastatic urothelial carcinoma: Multicenter retrospective study

被引：0
|
作者：
Kim, E. [1 ]
Kim, J. H. [2 ]
Chu, J. [3 ]
Lee, Y-G. [1 ]
Im, H-S. [4 ]
机构：
[1] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Hematol & Oncol, Sch Med, Seoul, South Korea
[2] Korea Univ, Anam Hosp, Dept Oncol Hematol, Seoul, South Korea
[3] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Pathol, Sch Med, Seoul, South Korea
[4] Ulsan Univ Hosp, Dept Hematol & Oncol, Ulsan, South Korea
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1033
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2384P
引用
收藏
页码：S1214 / S1214
页数：1
相关论文
共 50 条
  • [1] Rethinking prognostic factors in locally advanced or metastatic urothelial carcinoma in the immune checkpoint blockade era: a multicenter retrospective study
    Ruiz-Banobre, J.
    Molina-Diaz, A.
    Fernandez-Calvo, O.
    Fernandez-Nunez, N.
    Medina-Colmenero, A.
    Santome, L.
    Lazaro-Quintela, M.
    Mateos-Gonzalez, M.
    Garcia-Cid, N.
    Lopez-Lopez, R.
    Vazquez, S.
    Anido-Herranz, U.
    ESMO OPEN, 2021, 6 (02)
  • [2] Immune checkpoint inhibitor rechallenge in advanced hepatocellular carcinoma: A retrospective cohort study
    Chen, J-K.
    Su, J-Y.
    Peng, N-F.
    Ma, L.
    Zhong, J-H.
    ANNALS OF ONCOLOGY, 2024, 35 : S1490 - S1490
  • [3] Treatment Rechallenge With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma
    Makrakis, Dimitrios
    Bakaloudi, Dimitra Rafailia
    Talukder, Rafee
    Lin, Genevieve Ihsiu
    Diamantopoulos, Leonidas N.
    Jindal, Tanya
    Vather-Wu, Naomi
    Zakharia, Yousef
    Tripathi, Nishita
    Agarwal, Neeraj
    Dawsey, Scott
    Gupta, Shilpa
    Lu, Eric
    Drakaki, Alexandra
    Liu, Sandy
    Zakopoulou, Roubini
    Bamias, Aristotelis
    Fulgenzi, Claudia -Maria
    Cortellini, Alessio
    Pinato, David
    Barata, Pedro
    Grivas, Petros
    Khaki, Ali Raza
    Koshkin, Vadim S.
    CLINICAL GENITOURINARY CANCER, 2023, 21 (02) : 286 - 294
  • [4] A Review of Immune Checkpoint Inhibitors for the Management of Locally Advanced or Metastatic Urothelial Carcinoma
    Hanna, Kirollos S.
    PHARMACOTHERAPY, 2017, 37 (11): : 1391 - 1405
  • [5] Chemotherapy following immune checkpoint inhibitors in patients with locally advanced or metastatic urothelial carcinoma
    Meynard, Lucie
    Dinart, Derek
    Delaunay, Blandine
    Flechon, Aude
    Saldana, Carolina
    Lefort, Felix
    Gravis, Gwenaelle
    Thiery-Vuillemin, Antoine
    Cancel, Mathilde
    Coquan, Elodie
    Ladoire, Sylvain
    Maillet, Denis
    Rolland, Frederic
    Boughalem, Elouen
    Martin, Sophie
    Laramas, Mathieu
    Crouzet, Laurence
    Abbar, Baptiste
    Falkowski, Sabrina
    Pouessel, Damien
    Roubaud, Guilhem
    EUROPEAN JOURNAL OF CANCER, 2022, 175 : 43 - 53
  • [6] Immune checkpoint inhibitor rechallenge in advanced or metastatic non-small cell lung cancer: a retrospective cohort study
    Xu, Ziyi
    Hao, Xuezhi
    Yang, Ke
    Wang, Qi
    Wang, Jing
    Lin, Lin
    Teng, Fei
    Li, Junling
    Xing, Puyuan
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (11) : 3081 - 3089
  • [7] Immune checkpoint inhibitor rechallenge in advanced or metastatic non-small cell lung cancer: a retrospective cohort study
    Ziyi Xu
    Xuezhi Hao
    Ke Yang
    Qi Wang
    Jing Wang
    Lin Lin
    Fei Teng
    Junling Li
    Puyuan Xing
    Journal of Cancer Research and Clinical Oncology, 2022, 148 : 3081 - 3089
  • [8] Effectiveness and safety of immune checkpoint inhibitor monotherapy in advanced upper tract urothelial carcinoma: A multicenter, retrospective, real-world study
    Su, Ruopeng
    Chen, Zeyu
    Hong, Daoping
    Jiang, Shuai
    Yuan, Yichu
    Cai, Xingyun
    Hu, Hailong
    Fu, Changde
    Huang, Zhiyang
    Wang, Zhenyu
    Zheng, Bing
    Huang, Jian
    Wang, Zaoyu
    Bao, Yige
    Cai, Ming
    Guo, Jianming
    Chen, Minfeng
    Wei, Qiang
    Huang, Jiwei
    Xue, Wei
    CANCER MEDICINE, 2023, 12 (09): : 10587 - 10596
  • [9] Unexpected response to cisplatin rechallenge after immune checkpoint inhibitors in patients with metastatic urothelial carcinoma refractory to platinum regimen
    Gravis, Gwenaelle
    Billon, Emilien
    Baldini, Capucine
    Massard, Christophe
    Hilgers, Werner
    Delva, Remy
    Walz, Jochen
    Pignot, Geraldine
    Rybikowski, Stanislas
    Dermeche, Slimane
    Thomassin, Jeanne
    Brunelle, Serge
    Lavaud, Pernelle
    Loriot, Yohann
    EUROPEAN JOURNAL OF CANCER, 2018, 104 : 236 - 238
  • [10] Safety and efficacy of immune checkpoint inhibitor rechallenge in metastatic fumarate hydratase-deficient renal cell carcinoma: A retrospective study
    Tang, Y.
    Wang, M.
    Liang, J.
    Zeng, H.
    ANNALS OF ONCOLOGY, 2024, 35 : S1522 - S1522
12345